Nidan Laboratories & Healthcare Ltd.
Nidan Laboratories & Healthcare Ltd. (NIDAN.NS) Stock Overview
Explore Nidan Laboratories & Healthcare Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
193.2M
P/E Ratio
N/A
EPS (TTM)
$1.42
ROE
N/A
NIDAN.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Nidan Laboratories & Healthcare Ltd. (NIDAN.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.22.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 193.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.